Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-02-27
2007-02-27
Ewoldt, G. R. (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S387300
Reexamination Certificate
active
09992524
ABSTRACT:
The invention provides humanized immunoglobulins that bind to and neutralize γ-interferon. The antibodies are useful for treatment of diseases of the immune system, particularly autoimmune diseases.
REFERENCES:
patent: 5530101 (1996-06-01), Queen et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 6329511 (2001-12-01), Vasquez et al.
Chen, C., et al. J. Exp. Med. Sep. 1992; 176:855-866.
Colman, P.M., “Effects of amino acid sequence changes on antibody-antigen interactions,”Res. Immunology, 145:33-36 (1994).
Landolfi Nicholas F.
Queen Cary L.
Tsurushita Naoya
Vasquez Maximiliano
Ewoldt G. R.
PDL Biopharma, Inc.
Townsend and Townsend / and Crew LLP
LandOfFree
Humanized antibodies to gamma-interferon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Humanized antibodies to gamma-interferon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Humanized antibodies to gamma-interferon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3823936